Перейти к основному содержанию
AkademIndex

Продукты

Для разработчиков

AkademBaseОткрытый API экосистемы
Статья

Development of Risk Score for Predicting 3-Year Incidence of Type 2 Diabetes: Japan Epidemiology Collaboration on Occupational Health Study

Akiko NanriDepartment of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, JapanTohru NakagawaHitachi, Ltd., Ibaraki, JapanKeisuke KuwaharaDepartment of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, JapanShuichiro YamamotoHitachi, Ltd., Ibaraki, JapanToru HondaHitachi, Ltd., Ibaraki, JapanHiroko OkazakiMitsui Chemicals, Inc., Tokyo, JapanAkihiko UeharaYAMAHA CORPORATION, Shizuoka, JapanMakoto YamamotoYAMAHA CORPORATION, Shizuoka, JapanToshiaki MiyamotoNippon Steel & Sumitomo Metal Corporation Kimitsu Works, Chiba, JapanTakeshi KochiFurukawa Electric Co., Ltd., Tokyo, JapanMasafumi EguchiFurukawa Electric Co., Ltd., Tokyo, JapanTaizo MurakamiMizue Medical Clinic, Keihin Occupational Health Center, Kanagawa, JapanChii ShimizuMizue Medical Clinic, Keihin Occupational Health Center, Kanagawa, JapanMakiko ShimizuMizue Medical Clinic, Keihin Occupational Health Center, Kanagawa, JapanKentaro TomitaMitsubishi Plastics, Inc., Tokyo, JapanSatsue NagahamaTeppei ImaiAzbil Corporation, Tokyo, JapanAkiko NishiharaAzbil Corporation, Tokyo, JapanNaoko SasakiMitsubishi Fuso Truck and Bus Corporation, Kanagawa, JapanAi HoriDepartment of Safety and Health, Tokyo Gas Co., Ltd., Tokyo, JapanNobuaki SakamotoChihiro NishiuraDepartment of Safety and Health, Tokyo Gas Co., Ltd., Tokyo, JapanTakafumi TotsuzakiMizuho Health Insurance Society, Tokyo, JapanNoritada KatoFuji Electric Co., Ltd., Kanagawa, JapanKenji FukasawaHuanhuan HuDepartment of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, JapanShamima AkterDepartment of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, JapanKayo KurotaniDepartment of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, JapanIsamu KabeFurukawa Electric Co., Ltd., Tokyo, JapanTetsuya MizoueDepartment of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, JapanTomofumi SoneNational Institute of Public Health, Saitama, JapanSeitaro DohiMitsui Chemicals, Inc., Tokyo, Japan
2015en
ABI

Аннотация

OBJECTIVE: Risk models and scores have been developed to predict incidence of type 2 diabetes in Western populations, but their performance may differ when applied to non-Western populations. We developed and validated a risk score for predicting 3-year incidence of type 2 diabetes in a Japanese population. METHODS: Participants were 37,416 men and women, aged 30 or older, who received periodic health checkup in 2008-2009 in eight companies. Diabetes was defined as fasting plasma glucose (FPG) ≥ 126 mg/dl, random plasma glucose ≥ 200 mg/dl, glycated hemoglobin (HbA1c) ≥ 6.5%, or receiving medical treatment for diabetes. Risk scores on non-invasive and invasive models including FPG and HbA1c were developed using logistic regression in a derivation cohort and validated in the remaining cohort. RESULTS: The area under the curve (AUC) for the non-invasive model including age, sex, body mass index, waist circumference, hypertension, and smoking status was 0.717 (95% CI, 0.703-0.731). In the invasive model in which both FPG and HbA1c were added to the non-invasive model, AUC was increased to 0.893 (95% CI, 0.883-0.902). When the risk scores were applied to the validation cohort, AUCs (95% CI) for the non-invasive and invasive model were 0.734 (0.715-0.753) and 0.882 (0.868-0.895), respectively. Participants with a non-invasive score of ≥ 15 and invasive score of ≥ 19 were projected to have >20% and >50% risk, respectively, of developing type 2 diabetes within 3 years. CONCLUSIONS: The simple risk score of the non-invasive model might be useful for predicting incident type 2 diabetes, and its predictive performance may be markedly improved by incorporating FPG and HbA1c.

Перевод пока недоступен

Идентификаторы

Цитирования и источники

Цитирований: 2Использованных источников: 0